Effect of subchronic exposure to tetradifon on bone remodelling and metabolism in female rat.
This study investigates the effect of subchronic exposure to tetradifon, an organochlorine pesticide with an oestrogen-like structure, in female rat. A single cumulative dose of 2430 mg/kg BW was administrated orally for 12 female rats of 190 g BW. Twelve non-treated additional rats have served as controls. Animals were sacrificed after 6 and 12 weeks of treatment. We studied bone remodelling through histomorphometry and scanning electron microscopy (SEM) analyses. The serum and the right femora were used to determine phosphatase alkaline (AlkP) and/or calcium and phosphorus content. No sign of toxicity was observed until the end of the experiment. The SEM results revealed no structural alteration of the treated animal bone tissue. However, in both treated groups, we have noted an increase in the trabecular distance and a heterogeneous aspect of the endosteum that could be explained by bone-remodelling disturbance, with relative delay of ossification. Following histomorphomotric analysis, these results were coupled with significant increases in Tb.Th and OS/BS. Elsewhere, tetradifon intoxication increased significant serum AlkP level in the group treated for 12 weeks, which could be explained by an osteoblastic hyperactivity. Tetradifon intoxication decreased significantly bone calcium end phosphorus contents. Tetradifon seems not to exert major effects on bone remodelling. However, the osteoblastic hyperactivity could be explained by the oestrogen-like activity of tetradifon and its fatty metabolism. In fact, oestrogen inhibits bone remodelling, and enhances bone formation, which could result in an increase of the osteoid surface and explain the relative delay of ossification.
Badraoui
Riadh
R
Laboratoire d'histologie-embryologie, faculté de médecine de Sfax, rue Majida-Boulila, 3029 Sfax, Tunisie. riadh.badraoui@etud.univ-angers.fr
Abdelmoula
Nouha Bouayed
NB
Sahnoun
Zouhaier
Z
Fakhfakh
Zouhaier
Z
Rebai
Tarek
T
D000469:Alkaline Phosphatase / Q000097:blood / Q000187:drug effects; D000704:Analysis of Variance; D000818:Animals; D016723:Bone Remodeling / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D005260:Female; D005269:Femur / Q000187:drug effects / Q000648:ultrastructure; D006843:Hydrocarbons, Chlorinated / Q000494:pharmacology*; D008855:Microscopy, Electron, Scanning; D010758:Phosphorus / Q000378:metabolism; D051381:Rats
D006843:Hydrocarbons, Chlorinated; D010758:Phosphorus; D000469:Alkaline Phosphatase; D002118:Calcium; C005807:tetradifon